Home/Filings/4/0001209191-18-042396
4//SEC Filing

Routti Jorma 4

Accession 0001209191-18-042396

CIK 0000921299other

Filed

Jul 10, 8:00 PM ET

Accepted

Jul 11, 6:59 PM ET

Size

8.6 KB

Accession

0001209191-18-042396

Insider Transaction Report

Form 4
Period: 2018-07-09
Routti Jorma
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2018-07-09$18.00/sh+6,000$108,000137,540 total
  • Sale

    Common Stock

    2018-07-09$67.71/sh6,000$406,260131,540 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-07-096,0006,000 total
    Exercise: $18.00Exp: 2024-11-13Common Stock (6,000 underlying)
Footnotes (3)
  • [F1]Shares sold pursuant to a 10b5-1 plan.
  • [F2]The shares were sold at prices ranging from $67.25 to $68.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Fully vested.

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeother

Related Parties

1
  • filerCIK 0001621330

Filing Metadata

Form type
4
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 6:59 PM ET
Size
8.6 KB